7-octadecynoic acid

7-octadecynoic acid is a lipid of Fatty Acyls (FA) class.

Cross Reference

There are no associated biomedical information in the current reference collection.

Current reference collection contains 19785 references associated with 7-octadecynoic acid in LipidPedia. Due to lack of full text of references or no associated biomedical terms are recognized in our current text-mining method, we cannot extract any biomedical terms related to diseases, pathways, locations, functions, genes, lipids, and animal models from the associated reference collection.

Users can download the reference list at the bottom of this page and read the reference manually to find out biomedical information.


Here are additional resources we collected from PubChem and MeSH for 7-octadecynoic acid

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with 7-octadecynoic acid

MeSH term MeSH ID Detail
Legg-Calve-Perthes Disease D007873 1 associated lipids
Fluorosis, Dental D009050 1 associated lipids
Bone Demineralization, Pathologic D018488 1 associated lipids
Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative D054438 1 associated lipids
Hashimoto Disease D050031 1 associated lipids
POEMS Syndrome D016878 1 associated lipids
Fibroma, Ossifying D018214 1 associated lipids
Osteolysis, Essential D010015 1 associated lipids
Osteoporotic Fractures D058866 1 associated lipids
Hemangioma, Capillary D018324 1 associated lipids
Dentin Dysplasia D003805 1 associated lipids
Neoplasms, Squamous Cell D018307 1 associated lipids
Cleidocranial Dysplasia D002973 1 associated lipids
Prediabetic State D011236 1 associated lipids
Rheumatic Fever D012213 1 associated lipids
Chronic Periodontitis D055113 1 associated lipids
Intracranial Hemorrhage, Traumatic D020198 1 associated lipids
Neoplastic Syndromes, Hereditary D009386 1 associated lipids
Scleroderma, Limited D045745 1 associated lipids
Vestibulocochlear Nerve Diseases D000160 1 associated lipids
Dental Pulp Exposure D003789 1 associated lipids
Dental Occlusion, Traumatic D003769 1 associated lipids
Hemarthrosis D006395 1 associated lipids
Cherubism D002636 1 associated lipids
Arthropathy, Neurogenic D001177 1 associated lipids
Giant Cell Tumor of Bone D018212 1 associated lipids
Mandibular Injuries D008338 1 associated lipids
Diabetic Foot D017719 1 associated lipids
Bisphosphonate-Associated Osteonecrosis of the Jaw D059266 1 associated lipids
Emphysema D004646 1 associated lipids
Arteriolosclerosis D050379 1 associated lipids
Tooth Ankylosis D020254 1 associated lipids
Spondylarthropathies D025242 1 associated lipids
Lymphangioleiomyomatosis D018192 1 associated lipids
Carcinoid Heart Disease D002275 1 associated lipids
Alphavirus Infections D018354 1 associated lipids
Ankylosis D000844 1 associated lipids
Jaw, Edentulous D007575 1 associated lipids
Chondrocalcinosis D002805 1 associated lipids
Synovitis, Pigmented Villonodular D013586 1 associated lipids
Periostitis D010522 1 associated lipids
Prosthesis Failure D011475 1 associated lipids
Spondylarthritis D025241 1 associated lipids
Foot Injuries D018409 1 associated lipids
Hyperphosphatemia D054559 1 associated lipids
Osteopetrosis D010022 1 associated lipids
Histiocytosis, Langerhans-Cell D006646 1 associated lipids
Jaw, Edentulous, Partially D007576 1 associated lipids
Bone Diseases, Endocrine D001849 1 associated lipids
Angioid Streaks D000793 1 associated lipids
Atrial Remodeling D064752 1 associated lipids
Chondroblastoma D002804 1 associated lipids
Tooth Resorption D014091 1 associated lipids
Vascular Calcification D061205 1 associated lipids
Hip Dislocation D006617 1 associated lipids
Rupture, Spontaneous D012422 1 associated lipids
Malocclusion, Angle Class I D008311 1 associated lipids
Hyperostosis D015576 1 associated lipids
Adrenocortical Adenoma D018246 1 associated lipids
Hyperparathyroidism, Primary D049950 1 associated lipids
Breast Neoplasms, Male D018567 1 associated lipids
Severe Combined Immunodeficiency D016511 1 associated lipids
Peri-Implantitis D057873 1 associated lipids
Eye Neoplasms D005134 2 associated lipids
Lithiasis D020347 2 associated lipids
Labyrinthitis D007762 2 associated lipids
Cholesteatoma, Middle Ear D018424 2 associated lipids
Hypertension, Pregnancy-Induced D046110 2 associated lipids
Pasteurellaceae Infections D016871 2 associated lipids
Dental Pulp Calcification D003784 2 associated lipids
Bone Diseases, Developmental D001848 2 associated lipids
Bone Cysts, Aneurysmal D017824 2 associated lipids
Actinomycosis D000196 2 associated lipids
Fractures, Stress D015775 2 associated lipids
Osteosclerosis D010026 2 associated lipids
Carcinoma, Neuroendocrine D018278 2 associated lipids
Osteophyte D054850 2 associated lipids
Pericardial Effusion D010490 2 associated lipids
Lymphocytosis D008218 2 associated lipids
Prenatal Exposure Delayed Effects D011297 2 associated lipids
Radicular Cyst D011842 2 associated lipids
Gingival Recession D005889 2 associated lipids
Carcinoma, Medullary D018276 2 associated lipids
Tooth Migration D014085 2 associated lipids
Dengue D003715 2 associated lipids
Foot Deformities, Acquired D005531 2 associated lipids
Musculoskeletal Diseases D009140 2 associated lipids
Ossification, Heterotopic D009999 2 associated lipids
No-Reflow Phenomenon D054318 2 associated lipids
Adrenal Hyperplasia, Congenital D000312 2 associated lipids
Angina, Stable D060050 2 associated lipids
Sarcoma, Ewing D012512 2 associated lipids
Urologic Neoplasms D014571 2 associated lipids
Tooth Mobility D014086 2 associated lipids
Otosclerosis D010040 2 associated lipids
Hip Fractures D006620 2 associated lipids
Root Resorption D012391 2 associated lipids
Bacteroidaceae Infections D016866 2 associated lipids
Microvascular Angina D017566 2 associated lipids
Bone Marrow Neoplasms D019046 2 associated lipids
Per page 10 20 50 100 | Total 298

All references with 7-octadecynoic acid

Download all related citations
Per page 10 20 50 100 | Total 4091
Authors Title Published Journal PubMed Link
Sagar DR et al. Osteoprotegerin reduces the development of pain behaviour and joint pathology in a model of osteoarthritis. 2014 Ann. Rheum. Dis. pmid:23723320
Bjerre M et al. Osteoprotegerin independently predicts mortality in patients with stable coronary artery disease: the CLARICOR trial. 2014 Scand. J. Clin. Lab. Invest. pmid:25026506
Liu M et al. Curculigoside improves osteogenesis of human amniotic fluid-derived stem cells. 2014 Stem Cells Dev. pmid:24007307
Guo L et al. Association between seven common OPG genetic polymorphisms and osteoporosis risk: a meta-analysis. 2014 DNA Cell Biol. pmid:24283361
Samara S et al. Expression profile of osteoprotegerin, RANK and RANKL genes in the femoral head of patients with avascular necrosis. 2014 Exp. Mol. Pathol. pmid:24200492
Casarin RC et al. Resveratrol improves bone repair by modulation of bone morphogenetic proteins and osteopontin gene expression in rats. 2014 Int J Oral Maxillofac Surg pmid:24530035
Zhao H et al. Long-term resveratrol treatment prevents ovariectomy-induced osteopenia in rats without hyperplastic effects on the uterus. 2014 Br. J. Nutr. pmid:24073920
Puato M et al. Impact of hypertension on vascular remodeling in patients with psoriatic arthritis. 2014 J Hum Hypertens pmid:23842084
Ghorbanihaghjo A et al. Osteoprotegerin and soluble receptor activator of nuclear factor-kappa B ligand in exudative age-related macular degeneration. 2014 Acta Med Iran pmid:24901855
Dzgoeva FU et al. [Osteoprotegerin and fibroblast growth factor 23 in the development of cardiovascular events in chronic kidney disease]. 2014 Ter. Arkh. pmid:25095658
Honma M et al. Regulatory mechanisms of RANKL presentation to osteoclast precursors. 2014 Curr Osteoporos Rep pmid:24477414
Lewis JR et al. Elevated osteoprotegerin predicts declining renal function in elderly women: a 10-year prospective cohort study. 2014 Am. J. Nephrol. pmid:24457210
Cao H et al. Preoperative serum receptor activator of nuclear factor-κB ligand/osteoprotegerin predict stabilization of spontaneously restored sinus rhythm in persistent atrial fibrillation patients after mitral valve surgery. 2014 Cardiology pmid:24434592
Miller RE et al. RANKL inhibition blocks osteolytic lesions and reduces skeletal tumor burden in models of non-small-cell lung cancer bone metastases. 2014 J Thorac Oncol pmid:24496001
Lim WH et al. Downregulation of Wnt causes root resorption. 2014 Am J Orthod Dentofacial Orthop pmid:25172256
Wang F et al. Association analysis between g.18873C>T and g.27522G>A genetic polymorphisms of OPG and bone mineral density in Chinese postmenopausal women. 2014 Biomed Res Int pmid:25580430
Ostrowska Z et al. Selected adipose tissue hormones, bone metabolism, osteoprotegerin and receptor activator of nuclear factor-kB ligand in postmenopausal obese women. 2014 Endokrynol Pol pmid:25554611
Shen A et al. Role of osteoprotegerin and its gene polymorphisms in the occurrence of left ventricular hypertrophy in essential hypertensive patients. 2014 Medicine (Baltimore) pmid:25546658
Dessein PH et al. Independent relationship of osteoprotegerin concentrations with endothelial activation and carotid atherosclerosis in patients with severe rheumatoid arthritis. 2014 J. Rheumatol. pmid:24488413
Irtiuga OB et al. [Concentration of osteoprotegerin and RANKL in blood serum of patients with aortic stenosis]. 2014 Kardiologiia pmid:25178077
MacMillan AK et al. Similar healthy osteoclast and osteoblast activity on nanocrystalline hydroxyapatite and nanoparticles of tri-calcium phosphate compared to natural bone. 2014 Int J Nanomedicine pmid:25506216
Tella SH and Gallagher JC Prevention and treatment of postmenopausal osteoporosis. 2014 J. Steroid Biochem. Mol. Biol. pmid:24176761
Jiang Y et al. Achyranthes bidentata extract exerts osteoprotective effects on steroid-induced osteonecrosis of the femoral head in rats by regulating RANKL/RANK/OPG signaling. 2014 J Transl Med pmid:25471933
Lenglet S et al. Statin treatment is associated with reduction in serum levels of receptor activator of NF-κB ligand and neutrophil activation in patients with severe carotid stenosis. 2014 Mediators Inflamm. pmid:24648660
Takeshita S et al. Age-related marrow adipogenesis is linked to increased expression of RANKL. 2014 J. Biol. Chem. pmid:24753250
Akiyama T et al. Porphyromonas gingivalis-derived lysine gingipain enhances osteoclast differentiation induced by tumor necrosis factor-α and interleukin-1β but suppresses that by interleukin-17A: importance of proteolytic degradation of osteoprotegerin by lysine gingipain. 2014 J. Biol. Chem. pmid:24755218
Titanji K et al. Dysregulated B cell expression of RANKL and OPG correlates with loss of bone mineral density in HIV infection. 2014 PLoS Pathog. pmid:25393853
Akiyama N et al. Limitation of immune tolerance-inducing thymic epithelial cell development by Spi-B-mediated negative feedback regulation. 2014 J. Exp. Med. pmid:25385757
Lv Y et al. Effects of pamidronate disodium on the loss of osteoarthritic subchondral bone and the expression of cartilaginous and subchondral osteoprotegerin and RANKL in rabbits. 2014 BMC Musculoskelet Disord pmid:25377946
D'Abramo A et al. Immune activation, immunosenescence, and osteoprotegerin as markers of endothelial dysfunction in subclinical HIV-associated atherosclerosis. 2014 Mediators Inflamm. pmid:25374442
Samir SM and Malek HA Effect of cannabinoid receptors 1 modulation on osteoporosis in a rat model of different ages. 2014 J. Physiol. Pharmacol. pmid:25371528
Arrigoni C et al. Direct but not indirect co-culture with osteogenically differentiated human bone marrow stromal cells increases RANKL/OPG ratio in human breast cancer cells generating bone metastases. 2014 Mol. Cancer pmid:25335447
Zhang X et al. Ultrastructural characterization of the implant interface response to loading. 2014 J. Dent. Res. pmid:24389808
Lv Z et al. Bone morphogenetic protein 9 regulates tumor growth of osteosarcoma cells through the Wnt/β-catenin pathway. 2014 Oncol. Rep. pmid:24337584
Cardelli M and Aubin JE ERRγ is not required for skeletal development but is a RUNX2-dependent negative regulator of postnatal bone formation in male mice. 2014 PLoS ONE pmid:25313644
Kim JY et al. (2S)-2'-Methoxykurarinone inhibits osteoclastogenesis and bone resorption through down-regulation of RANKL signaling. 2014 Biol. Pharm. Bull. pmid:24492722
Movérare-Skrtic S et al. Osteoblast-derived WNT16 represses osteoclastogenesis and prevents cortical bone fragility fractures. 2014 Nat. Med. pmid:25306233
Hayashida C et al. Osteocytes produce interferon-β as a negative regulator of osteoclastogenesis. 2014 J. Biol. Chem. pmid:24610813
Callegari A et al. Increased calcification in osteoprotegerin-deficient smooth muscle cells: Dependence on receptor activator of NF-κB ligand and interleukin 6. 2014 J. Vasc. Res. pmid:24642764
Wohlfahrt JC et al. Sulcus fluid bone marker levels and the outcome of surgical treatment of peri-implantitis. 2014 J. Clin. Periodontol. pmid:24417563
Park SY et al. Betulinic acid, a bioactive pentacyclic triterpenoid, inhibits skeletal-related events induced by breast cancer bone metastases and treatment. 2014 Toxicol. Appl. Pharmacol. pmid:24463094
Zhang Z et al. High-dose diosgenin reduces bone loss in ovariectomized rats via attenuation of the RANKL/OPG ratio. 2014 Int J Mol Sci pmid:25257532
Kang JH et al. Osteoprotegerin expressed by osteoclasts: an autoregulator of osteoclastogenesis. 2014 J. Dent. Res. pmid:25256714
Cao H et al. Force-induced Adrb2 in periodontal ligament cells promotes tooth movement. 2014 J. Dent. Res. pmid:25252876
Prates TP et al. NOD2 contributes to Porphyromonas gingivalis-induced bone resorption. 2014 J. Dent. Res. pmid:25239844
Yamamoto N et al. Regulation by resveratrol of prostaglandin E2-stimulated osteoprotegerin synthesis in osteoblasts. 2014 Int. J. Mol. Med. pmid:25234201
Olivares-Navarrete R et al. Osteoblast lineage cells can discriminate microscale topographic features on titanium-aluminum-vanadium surfaces. 2014 Ann Biomed Eng pmid:25227453
Giuliani AL et al. Trophic activity of human P2X7 receptor isoforms A and B in osteosarcoma. 2014 PLoS ONE pmid:25226385
Köttstorfer J et al. Are OPG and RANKL involved in human fracture healing? 2014 J. Orthop. Res. pmid:25212894
Esteghamati A et al. Serum osteoprotegerin in relation to metabolic status, severity, and estimated risk of subsequent coronary heart disease. 2014 Arch Iran Med pmid:25204474
Jasiewicz M et al. Potential pathogenic role of soluble receptor activator of nuclear factor-ĸB ligand and osteoprotegerin in patients with pulmonary arterial hypertension. 2014 Pol. Arch. Med. Wewn. pmid:25188298
Liu YD et al. Reducing dietary loading decreases mouse temporomandibular joint degradation induced by anterior crossbite prosthesis. 2014 Osteoarthr. Cartil. pmid:24316289
Genre F et al. Osteoprotegerin CGA haplotype protection against cerebrovascular complications in anti-CCP negative patients with rheumatoid arthritis. 2014 PLoS ONE pmid:25184828
Zhang YD et al. Association of the g.19074G>A genetic variant in the osteoprotegerin gene with bone mineral density in Chinese postmenopausal women. 2014 Genet. Mol. Res. pmid:25177945
Bandeira F et al. Bone markers and osteoporosis therapy. 2014 Arq Bras Endocrinol Metabol pmid:25166041
Foo JP et al. The effect of leptin replacement on parathyroid hormone, RANKL-osteoprotegerin axis, and Wnt inhibitors in young women with hypothalamic amenorrhea. 2014 J. Clin. Endocrinol. Metab. pmid:25148234
Kuroyanagi G et al. Resveratrol suppresses prostaglandin F(2α)-induced osteoprotegerin synthesis in osteoblasts: inhibition of the MAP kinase signaling. 2014 Arch. Biochem. Biophys. pmid:24333336
Warren JT et al. Manipulation of receptor oligomerization as a strategy to inhibit signaling by TNF superfamily members. 2014 Sci Signal pmid:25140055
Jung Koo H et al. Effect of the combinatory mixture of Rubus coreanus Miquel and Astragalus membranaceus Bunge extracts on ovariectomy-induced osteoporosis in mice and anti-RANK signaling effect. 2014 J Ethnopharmacol pmid:24333364
Yan D et al. Serum levels of M-CSF, RANKL and OPG in rats fed with Kashin-Beck disease-affected diet. 2014 J Orthop Surg Res pmid:25138985
Schieferdecker A et al. Denosumab mimics the natural decoy receptor osteoprotegerin by interacting with its major binding site on RANKL. 2014 Oncotarget pmid:25138051
Bosman MC et al. Decreased affinity of recombinant human tumor necrosis factor-related apoptosis-inducing ligand (rhTRAIL) D269H/E195R to osteoprotegerin (OPG) overcomes TRAIL resistance mediated by the bone microenvironment. 2014 J. Biol. Chem. pmid:24280212
Chung SL et al. Low-magnitude high-frequency vibration enhances gene expression related to callus formation, mineralization and remodeling during osteoporotic fracture healing in rats. 2014 J. Orthop. Res. pmid:25131218
Yoshida S et al. An osteoprotegerin gene polymorphism is associated with an increased risk of hip fracture in Japanese patients with rheumatoid arthritis: results from the IORRA Observational Cohort Study. 2014 PLoS ONE pmid:25105978
Li T et al. Rabbiteye blueberry prevents osteoporosis in ovariectomized rats. 2014 J Orthop Surg Res pmid:25102951
Kim YH et al. Enhancement of bone regeneration by dual release of a macrophage recruitment agent and platelet-rich plasma from gelatin hydrogels. 2014 Biomaterials pmid:24125774
Ohlsson C et al. Probiotics protect mice from ovariectomy-induced cortical bone loss. 2014 PLoS ONE pmid:24637895
Loureiro MB et al. Low bone mineral density is associated to poor glycemic control and increased OPG expression in children and adolescents with type 1 diabetes. 2014 Diabetes Res. Clin. Pract. pmid:24529565
Tera Tde M et al. The RANK/ RANKL/ OPG interaction in the repair of autogenous bone grafts in female rats with estrogen deficiency. 2014 Braz Oral Res pmid:25229791
Huang C et al. The inhibitory effect of strontium-doped calcium polyphosphate particles on cytokines from macrophages and osteoblasts leading to aseptic loosening in vitro. 2014 Biomed Mater pmid:24518283
Izawa A et al. Inflammatory bone loss in experimental periodontitis induced by Aggregatibacter actinomycetemcomitans in interleukin-1 receptor antagonist knockout mice. 2014 Infect. Immun. pmid:24566623
Knevel R et al. A genetic variant in osteoprotegerin is associated with progression of joint destruction in rheumatoid arthritis. 2014 Arthritis Res. Ther. pmid:24886600
Zinonos I et al. Pharmacologic inhibition of bone resorption prevents cancer-induced osteolysis but enhances soft tissue metastasis in a mouse model of osteolytic breast cancer. 2014 Int. J. Oncol. pmid:24865346
Todenhöfer T et al. Serum receptor activator of nuclear factor κB ligand (RANKL) levels predict biochemical recurrence in patients undergoing radical prostatectomy. 2014 BJU Int. pmid:23360112
Klimek E et al. Differential associations of inflammatory and endothelial biomarkers with disease activity in rheumatoid arthritis of short duration. 2014 Mediators Inflamm. pmid:24864133
Chen H et al. Runx2 regulates endochondral ossification through control of chondrocyte proliferation and differentiation. 2014 J. Bone Miner. Res. pmid:24862038
Li B et al. Periodontal ligament stem cells modulate root resorption of human primary teeth via Runx2 regulating RANKL/OPG system. 2014 Stem Cells Dev. pmid:24827498
Lee SI et al. NOD2 Mediates Odontoblast Differentiation and RANKL Expression. 2014 J. Dent. Res. pmid:24820666
Araújo AA et al. Azilsartan increases levels of IL-10, down-regulates MMP-2, MMP-9, RANKL/RANK, Cathepsin K and up-regulates OPG in an experimental periodontitis model. 2014 PLoS ONE pmid:24819928
Cianciolo G et al. Importance of vascular calcification in kidney transplant recipients. 2014 Am. J. Nephrol. pmid:24819032
Sänger N et al. OPG and PgR show similar cohort specific effects as prognostic factors in ER positive breast cancer. 2014 Mol Oncol pmid:24785095
Hidayat R et al. Correlation between receptor activator of nuclear factor-κβ ligand (RANKL), and osteoprotegerin (OPG) with cartilage degradation in rheumatoid arthritis patients. 2014 Acta Med Indones pmid:24760805
Milanova V et al. TLR2 elicits IL-17-mediated RANKL expression, IL-17, and OPG production in neutrophils from arthritic mice. 2014 Mediators Inflamm. pmid:24757287
Jiang XY et al. TNFRSF11B polymorphisms are associated with metabolic traits in Uyghur and Han ethnic groups. 2014 Endocr. Res. pmid:23772656
Nolen BM et al. Prediagnostic serum biomarkers as early detection tools for pancreatic cancer in a large prospective cohort study. 2014 PLoS ONE pmid:24747429
Zhao JJ et al. Association analysis between the OPG g.27667T>A genetic variant and bone mineral density in Chinese postmenopausal women. 2014 Genet. Mol. Res. pmid:24737508
Yoo YM et al. Effects of neuropeptides and mechanical loading on bone cell resorption in vitro. 2014 Int J Mol Sci pmid:24717410
Deng L et al. Tissue distribution of emulsified γ-tocotrienol and its long-term biological effects after subcutaneous administration. 2014 Lipids Health Dis pmid:24712339
Chung PL et al. Effect of age on regulation of human osteoclast differentiation. 2014 J. Cell. Biochem. pmid:24700654
Shao X et al. Metformin rescues the MG63 osteoblasts against the effect of high glucose on proliferation. 2014 J Diabetes Res pmid:24812633
Sirjani M et al. The effects of high fat, low carbohydrate and low fat, high carbohydrate diets on tumor necrosis factor superfamily proteins and proinflammatory cytokines in C57BL/6 mice. 2014 Iran J Allergy Asthma Immunol pmid:24659160
Wang JH et al. Association of serum osteoprotegerin levels with carotid-femoral pulse wave velocity in hypertensive patients. 2014 J Clin Hypertens (Greenwich) pmid:24640954
Liu YP et al. Association of the g.27563G>A osteoprotegerin genetic polymorphism with bone mineral density in Chinese women. 2014 Genet. Mol. Res. pmid:24615112
Ovchinnikova OA et al. The collagen cross-linking enzyme lysyl oxidase is associated with the healing of human atherosclerotic lesions. 2014 J. Intern. Med. pmid:24588843
Montes de Oca A et al. Magnesium inhibits Wnt/β-catenin activity and reverses the osteogenic transformation of vascular smooth muscle cells. 2014 PLoS ONE pmid:24586847
Guo L et al. Effects of erythropoietin on osteoblast proliferation and function. 2014 Clin. Exp. Med. pmid:23135151
Ostrowska Z et al. Bone metabolism, osteoprotegerin, receptor activator of nuclear factor-κB ligand and selected adipose tissue hormones in girls with anorexia nervosa. 2014 Endokrynol Pol pmid:24549600
Chauvat A et al. Clinical validation of IFNγ/IL-10 and IFNγ/IL-2 FluoroSpot assays for the detection of Tr1 T cells and influenza vaccine monitoring in humans. 2014 Hum Vaccin Immunother pmid:24084262
Chaichanasakul T et al. Diverse osteoclastogenesis of bone marrow from mandible versus long bone. 2014 J. Periodontol. pmid:24003963
Navratilova Z et al. Osteoprotegerin gene polymorphism is not associated with prosthetic joint infection after total joint arthroplasty in the Czech population. 2014 Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub pmid:22660233

Table of Content